Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mismatch Repair01:36

Mismatch Repair

Overview
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revue medicale suisse·2026
Same author

Diagnostic management of suspected acute pulmonary embolism in the postpartum period.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018-2023.

Swiss medical weekly·2025
Same author

Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in patients with chronic lung disease: an individual-patient data meta-analysis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Revue medicale suisse·2025

Related Experiment Video

Updated: May 11, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)
08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)

Published on: November 4, 2016

Methicillin-resistant Staphylococcus aureus risk profiling: who are we missing?

Janet Pasricha1, Stephan Harbarth, Thibaud Koessler

  • 1Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, 4 Rue Gabrielle Perret-Gentil, Geneva 1211, Switzerland. stephan.harbarth@hcuge.ch.

Antimicrobial Resistance and Infection Control
|June 1, 2013
PubMed
Summary

A significant number of patients missed MRSA screening, particularly younger individuals, those transferred from other wards, and cancer patients. Understanding these missed cases is crucial for improving methicillin-resistant Staphylococcus aureus (MRSA) prediction tools.

More Related Videos

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Related Experiment Videos

Last Updated: May 11, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)
08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)

Published on: November 4, 2016

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Healthcare Management

Background:

  • Targeted screening for methicillin-resistant Staphylococcus aureus (MRSA) carriage is key for MRSA control.
  • Prediction tools are used to identify high-risk patients for screening.
  • Previous studies noted many eligible patients were not screened, but their characteristics were often undescribed.

Purpose of the Study:

  • To determine the rate and characteristics of patients missed by an MRSA screening program.
  • To assess the potential impact of missed patients on the accuracy of clinical prediction tools.

Main Methods:

  • Prospective screening of all patients admitted to 13 internal medicine wards at the University of Geneva Hospital (HUG) from March-June 2010.
  • Analysis of patient demographics and transfer status for those not screened.
  • Multivariate regression to identify characteristics associated with missed screening.

Main Results:

  • 13.6% (267/1968) of admitted patients failed to undergo MRSA screening.
  • Younger patients (<50 years), those transferred from other wards, and patients with a history of malignancy were more likely to be missed.
  • No significant difference in previous MRSA carriage rates between screened and unscreened groups.

Conclusions:

  • Patients missed by MRSA screening programs may introduce bias into risk prediction scores.
  • Reporting on the characteristics of missed patients is essential for accurate interpretation of MRSA prediction tools.